AcipHex
- Product NDC
- 68151-3834
- 11-digit product format
- 681513834
- Labeler code
- 68151
- Product ID
- 68151-3834_68239683-18b4-45e0-b132-db401924df17
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rabeprazole sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Carilion Materials Management
- Application
- NDA020973
- Marketing category
- NDA
- Marketing start
- 1999-08-19
- Marketing end
- 0000-00-00
- Substance
- RABEPRAZOLE SODIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68151-3834-3 | AcipHex | 1 in 1 PACKAGE | TABLET, DELAYED RELEASE | 1 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| RABEPRAZOLE SODIUM | ACTIVE INGREDIENT | 3L36P16U4R | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| RABEPRAZOLE | ACTIVE MOIETY | 32828355LL | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| ETHYLCELLULOSES | INACTIVE INGREDIENT | 7Z8S9VYZ4B | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68151-3834 | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] | 3 | Legacy NDC, 1 package rows | 20160806_001dd372-2692-4d6f-a71c-95e7056349a9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 68151-3834-3 | 68151383403 | 1 in 1 PACKAGE | Historical |